Soleno Therapeutics, Inc.
SLNO
$52.95
$0.020.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 96.04M | 20.89M | -78.45M | -181.08M | -198.23M |
| Total Depreciation and Amortization | 2.03M | 2.02M | 2.01M | 2.01M | 2.00M |
| Total Amortization of Deferred Charges | 35.00K | 35.00K | 26.00K | 17.00K | 8.00K |
| Total Other Non-Cash Items | 48.06M | 48.49M | 66.13M | 111.43M | 109.17M |
| Change in Net Operating Assets | -40.64M | -24.63M | -15.61M | -16.65M | -2.28M |
| Cash from Operations | 105.53M | 46.80M | -25.90M | -84.28M | -89.32M |
| Capital Expenditure | -108.00K | -73.00K | -23.00K | -213.00K | -212.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -186.63M | -201.71M | -69.96M | 25.72M | -87.29M |
| Cash from Investing | -186.74M | -201.78M | -69.98M | 25.51M | -87.50M |
| Total Debt Issued | -- | -- | 49.89M | 49.89M | 49.89M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 234.88M | 238.11M | 244.33M | 28.63M | 165.48M |
| Repurchase of Common Stock | -100.89M | -100.89M | -33.00K | -33.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.09M | -62.00K | -62.00K | -240.00K | -62.00K |
| Cash from Financing | 132.90M | 137.16M | 294.12M | 78.25M | 215.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.70M | -17.82M | 198.25M | 19.47M | 38.48M |